Reproterol

At Reproterol is an active ingredient that belongs to the group of beta-2 sympathomimetics. Reproterol can be used as a metered dose aerosol or as an injection solution and is primarily used to widen the bronchi and, in this context, often as an asthma therapy.

What is Reproterol?

Reproterol is one of the active ingredients that are used in various respiratory diseases. In this context he belongs to the group of beta-2 sympathomimetics. By definition, Reproterol is used primarily for those respiratory diseases that are characterized by a narrowing of the bronchi.

These diseases primarily include severe bronchial asthma or chronic obstructive pulmonary disease, COPD for short. If the active ingredient is to be used over a longer period of time, the experts advise to always combine the intake with an anti-inflammatory therapy.

This can be done, for example, with an active ingredient from the field of glucocorticoids. The main property of Reproterol is that it dilates the bronchi very quickly and also makes it easier to cough up when there is mucus.

Pharmacological effect

The active substance Reproterol can get into the bloodstream on the one hand in the form of an injection, but on the other hand it is also possible to use it in the form of a metered dose inhaler.

Regarding the effect - regardless of the type of application - it should be noted that the dosage depends on both the type of disease and its severity. The main effect of Reproterol as a beta 2 sympathomimetic is based on the fact that the cramped muscles of the bronchi are relaxed very quickly. The effect is specifically achieved by causing the sympathetic beta-2 adrenoceptors to relax.

This in turn leads to the bronchial tubes dilating and the patient normally no longer feels breathlessness. It also makes it easier for existing mucus to be coughed up. Reproterol can also have a certain preventive effect against asthma and COPD. The half-life of the active ingredient is around 1.5 hours.

Medical application & use

The drug Reproterol is most commonly used to treat bronchial asthma. In this context, it is often combined with cromoglicic acid, so that both prevention and treatment of certain respiratory diseases is possible.

In this case, the application consists on the one hand of bronchodilator therapy and on the other hand of a basic therapy that is anti-inflammatory. It can therefore be stated that Reproterol is used in those respiratory diseases in which a narrowing of the bronchi is a symptom.

This includes not only severe asthma attacks, but also, for example, chronic obstructive pulmonary disease. As a result, the active ingredient can also be used with existing allergies that have a negative effect on the bronchi. In addition, the remedy is effective in diseases of the respiratory tract, which are accompanied by stronger concealment. Reproterol is also commonly used for chronic bronchitis.

Risks & side effects

Almost every active ingredient that can be used to treat more serious diseases can cause side effects while taking it. This applies to the active ingredient Reproterol also, although it must be said that of course by no means all patients experience side effects.

The side effects that may be common or uncommon while using Reproterol include primarily headache, temporary palpitations, or restlessness. Muscle spasms or muscle tremors can also occur to the same extent. In addition to these, there may be other side effects, which, however, occur comparatively rarely. First and foremost problems with urination should be mentioned here.

There are also some side effects that are rarely observed. These include allergic reactions such as itching or rash, low blood platelets and inflammation in the kidneys. Skin bleeding or facial swelling may also occur. In addition, there may be an increase in blood sugar levels or a reduced potassium content, although there is currently no information on the frequency of these side effects of Reproterol.